| Quantifying prion disease penetrance using large population control cohorts EV Minikel, SM Vallabh, M Lek, K Estrada, KE Samocha, ... Science translational medicine 8 (322), 322ra9-322ra9, 2016 | 360 | 2016 |
| Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas J Felsberg, N Thon, S Eigenbrod, B Hentschel, MC Sabel, M Westphal, ... International journal of cancer 129 (3), 659-670, 2011 | 356 | 2011 |
| Hot spots in dynamic18FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas M Kunz, N Thon, S Eigenbrod, C Hartmann, R Egensperger, J Herms, ... Neuro-oncology 13 (3), 307-316, 2011 | 261 | 2011 |
| MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET? NL Jansen, V Graute, L Armbruster, B Suchorska, J Lutz, S Eigenbrod, ... European journal of nuclear medicine and molecular imaging 39, 1021-1029, 2012 | 202 | 2012 |
| Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice A Pfeifer, S Eigenbrod, S Al-Khadra, A Hofmann, G Mitteregger, M Moser, ... The Journal of clinical investigation 116 (12), 3204-3210, 2006 | 201 | 2006 |
| Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM B Suchorska, NL Jansen, J Linn, H Kretzschmar, H Janssen, S Eigenbrod, ... Neurology 84 (7), 710-719, 2015 | 182 | 2015 |
| Low values of 5‐hydroxymethylcytosine (5hmC), the “sixth base,” are associated with anaplasia in human brain tumors TFJ Kraus, D Globisch, M Wagner, S Eigenbrod, D Widmann, M Münzel, ... International Journal of Cancer 131 (7), 1577-1590, 2012 | 177 | 2012 |
| Prognostic significance of dynamic 18F-FET PET in newly diagnosed astrocytic high-grade glioma NL Jansen, B Suchorska, V Wenter, C Schmid-Tannwald, A Todica, ... Journal of Nuclear Medicine 56 (1), 9-15, 2015 | 168 | 2015 |
| Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patients NL Jansen, B Suchorska, V Wenter, S Eigenbrod, C Schmid-Tannwald, ... Journal of Nuclear Medicine 55 (2), 198-203, 2014 | 155 | 2014 |
| O6-methylguanine-DNA methyltransferase (MGMT) mRNA expression predicts outcome in malignant glioma independent of MGMT promoter methylation S Kreth, N Thon, S Eigenbrod, J Lutz, C Ledderose, R Egensperger, ... PloS one 6 (2), e17156, 2011 | 144 | 2011 |
| Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [18F]FET-PET imaging in intracranial WHO grade II and III gliomas NL Jansen, C Schwartz, V Graute, S Eigenbrod, J Lutz, R Egensperger, ... Neuro-oncology 14 (12), 1473-1480, 2012 | 109 | 2012 |
| IDH1 mutations in grade II astrocytomas are associated with unfavorable progression‐free survival and prolonged postrecurrence survival N Thon, S Eigenbrod, S Kreth, J Lutz, JC Tonn, H Kretzschmar, A Peraud, ... Cancer 118 (2), 452-460, 2012 | 95 | 2012 |
| Novel Molecular Stereotactic Biopsy Procedures Reveal Intratumoral Homogeneity of Loss of Heterozygosity of 1p/19q and TP53 Mutations in World Health … N Thon, S Eigenbrod, EM Grasbon-Frodl, M Ruiter, JH Mehrkens, S Kreth, ... Journal of Neuropathology & Experimental Neurology 68 (11), 1219-1228, 2009 | 80 | 2009 |
| Dynamic 18F‐FET PET in suspected WHO grade II gliomas defines distinct biological subgroups with different clinical courses N Thon, M Kunz, L Lemke, NL Jansen, S Eigenbrod, S Kreth, J Lutz, ... International journal of cancer 136 (9), 2132-2145, 2015 | 79 | 2015 |
| Molecular stereotactic biopsy technique improves diagnostic accuracy and enables personalized treatment strategies in glioma patients S Eigenbrod, R Trabold, D Brucker, C Erös, R Egensperger, ... Acta neurochirurgica 156, 1427-1440, 2014 | 68 | 2014 |
| Cerebral angiitis in four patients with chronic GVHD P Sostak, CS Padovan, S Eigenbrod, S Roeber, S Segerer, C Schankin, ... Bone marrow transplantation 45 (7), 1181-1188, 2010 | 68 | 2010 |
| ALDH1A1 is a marker of astrocytic differentiation during brain development and correlates with better survival in glioblastoma patients SA Adam, O Schnell, J Pöschl, S Eigenbrod, HA Kretzschmar, JC Tonn, ... Brain pathology 22 (6), 788-797, 2012 | 67 | 2012 |
| Predominant influence of MGMT methylation in non-resectable glioblastoma after radiotherapy plus temozolomide N Thon, S Eigenbrod, EM Grasbon-Frodl, J Lutz, S Kreth, G Popperl, ... Journal of Neurology, Neurosurgery & Psychiatry 82 (4), 441-446, 2011 | 65 | 2011 |
| MiRNA expression patterns predict survival in glioblastoma M Niyazi, F Zehentmayr, OM Niemöller, S Eigenbrod, H Kretzschmar, ... Radiation Oncology 6, 1-8, 2011 | 62 | 2011 |
| FET-PET assessed recurrence pattern after radio-chemotherapy in newly diagnosed patients with glioblastoma is influenced by MGMT methylation status M Niyazi, O Schnell, B Suchorska, SB Schwarz, U Ganswindt, J Geisler, ... Radiotherapy and Oncology 104 (1), 78-82, 2012 | 60 | 2012 |
